Pandolfino, J. E. & Gawron, A. J. Achalasia: a systematic review. JAMA 313, 1841–1852 (2015).
Vaezi, M. F. et al. ACG clinical guidelines: diagnosis and management of achalasia. Am. J. Gastroenterol. 115, 1393–1411 (2020).
Yadlapati, R. et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0((c)). Neurogastroenterol. Motil. 33, e14058 (2021).
PubMed PubMed Central Google Scholar
Gergely, M. et al. Duration of symptoms and manometric parameters offer clues to diagnosis of pseudoachalasia. Neurogastroenterol. Motil. 33, e13965 (2021).
Furuzawa-Carballeda, J. et al. Achalasia — an autoimmune inflammatory disease: a cross-sectional study. J. Immunol. Res. 2015, 729217 (2015).
CAS PubMed PubMed Central Google Scholar
De Giorgio, R. et al. Esophageal and gastric nitric oxide synthesizing innervation in primary achalasia. Am. J. Gastroenterol. 94, 2357–2362 (1999).
Kilic, A. et al. Variations in inflammation and nerve fiber loss reflect different subsets of achalasia patients. J. Surg. Res. 143, 177–182 (2007).
Moses, P. L. et al. Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut 52, 629–636 (2003).
CAS PubMed PubMed Central Google Scholar
Gaber, C. E. et al. Autoimmune and viral risk factors are associated with achalasia: a case-control study. Neurogastroenterol. Motil. https://doi.org/10.1111/nmo.14312 (2021).
Naik, R. D. et al. Association of achalasia with active Varicella zoster virus infection of the esophagus. Gastroenterology 161, 719–721 e2 (2021).
Facco, M. et al. T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. Am. J. Gastroenterol. 103, 1598–1609 (2008).
Sodikoff, J. B. et al. Histopathologic patterns among achalasia subtypes. Neurogastroenterol. Motil. 28, 139–145 (2016).
Reddy, C. A. et al. Per-oral endoscopic myotomy biopsies of achalasia patients reveal Schwann cell depletion in the muscularis propria. Clin. Gastroenterol. Hepatol. 19, 1294–1295 (2021).
Sato, H. et al. Epidemiological analysis of achalasia in Japan using a large-scale claims database. J. Gastroenterol. 54, 621–627 (2019).
van Hoeij, F. B. et al. Incidence and costs of achalasia in The Netherlands. Neurogastroenterol. Motil. https://doi.org/10.1111/nmo.13195 (2018).
Harvey, P. R. et al. Incidence, morbidity and mortality of patients with achalasia in England: findings from a study of nationwide hospital and primary care data. Gut 68, 790–795 (2019).
Sadowski, D. C. et al. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol. Motil. 22, e256–e261 (2010).
Samo, S. et al. Incidence and prevalence of achalasia in central Chicago, 2004-2014, since the widespread use of high-resolution manometry. Clin. Gastroenterol. Hepatol. 15, 366–373 (2017).
Duffield, J. A. et al. Incidence of achalasia in South Australia based on esophageal manometry findings. Clin. Gastroenterol. Hepatol. 15, 360–365 (2017).
Gaber, C. E. et al. Epidemiologic and economic burden of achalasia in the United States. Clin. Gastroenterol. Hepatol. 20, 342–352.e5. (2021).
Roman, S. et al. High-resolution manometry improves the diagnosis of esophageal motility disorders in patients with dysphagia: a randomized multicenter study. Am. J. Gastroenterol. 111, 372–80. (2016).
Wadhwa, V. et al. Changing trends in age, gender, racial distribution and inpatient burden of achalasia. Gastroenterol. Res. 10, 70–77 (2017).
Gregersen, H. & Lo, K. M. Pathophysiology and treatment of achalasia in a muscle mechanical perspective. Ann. N. Y. Acad. Sci. 1434, 173–184 (2018).
Behar, J. & Biancani, P. Pathogenesis of simultaneous esophageal contractions in patients with motility disorders. Gastroenterology 105, 111–118 (1993).
Sifrim, D., Janssens, J. & Vantrappen, G. Failing deglutitive inhibition in primary esophageal motility disorders. Gastroenterology 106, 875–882 (1994).
Fornari, F. et al. Multiple rapid swallowing: a complementary test during standard oesophageal manometry. Neurogastroenterol. Motil. 21, 718–e41 (2009).
Savojardo, D. et al. Multiple rapid swallowing in idiopathic achalasia: evidence for patients’ heterogeneity. Neurogastroenterol. Motil. 19, 263–269 (2007).
Kushnir, V., Sayuk, G. S. & Gyawali, C. P. Multiple rapid swallow responses segregate achalasia subtypes on high-resolution manometry. Neurogastroenterol. Motil. 24, 1069–e561 (2012).
CAS PubMed PubMed Central Google Scholar
Murray, J. A. et al. The effects of recombinant human hemoglobin on esophageal motor functions in humans. Gastroenterology 109, 1241–1248 (1995).
Aggestrup, S. et al. Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. Gastroenterology 84, 924–927 (1983).
Mearin, F. et al. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur. J. Clin. Invest. 23, 724–728 (1993).
Yamato, S., Saha, J. K. & Goyal, R. K. Role of nitric oxide in lower esophageal sphincter relaxation to swallowing. Life Sci. 50, 1263–1272 (1992).
Dodds, W. J. et al. Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia. Gastroenterology 80, 327–333 (1981).
Cohen, S., Fisher, R. & Tuch, A. The site of denervation in achalasia. Gut 13, 556–558 (1972).
CAS PubMed PubMed Central Google Scholar
Booy, J. D. et al. The prevalence of autoimmune disease in patients with esophageal achalasia. Dis. Esophagus 25, 209–213 (2012).
King, D. et al. Achalasia is associated with atopy in patients younger than 40 years of age. Am. J. Gastroenterol. 116, 416–419 (2021).
Romero-Hernández, F. et al. Autoimmune comorbidity in achalasia patients. J. Gastroenterol. Hepatol. 33, 203–208 (2018).
Sara, C. et al. Clinical correlation and disease phenotype in patients with esophageal achalasia and comorbid autoimmune diseases. Dis. Esophagus 34, doaa072 (2021).
Becker, J. et al. Comprehensive epidemiological and genotype-phenotype analyses in a large European sample with idiopathic achalasia. Eur. J. Gastroenterol. Hepatol. 28, 689–695 (2016).
Becker, J. et al. The HLA-DQβ1 insertion is a strong achalasia risk factor and displays a geospatial north-south gradient among Europeans. Eur. J. Hum. Genet. 24, 1228–1231 (2016).
CAS PubMed PubMed Central Google Scholar
Furuzawa-Carballeda, J. et al. An original Eurasian haplotype, HLA-DRB1*14:54-DQB1*05:03, influences the susceptibility to idiopathic achalasia. PLoS ONE 13, e0201676 (2018).
PubMed PubMed Central Google Scholar
Vackova, Z. et al. First genotype-phenotype study reveals HLA-DQβ1 insertion heterogeneity in high-resolution manometry achalasia subtypes. United European Gastroenterol. J. 7, 45–51 (2019).
Goldblum, J. R., Rice, T. W. & Richter, J. E. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 111, 648–654 (1996).
Villanacci, V. et al. An immunohistochemical study of the myenteric plexus in idiopathic achalasia. J. Clin. Gastroenterol. 44, 407–410 (2010).
Clark, S. B. et al. The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am. J. Surg. Pathol. 24, 1153–1158 (2000).
Spechler, S. J., Konda, V. & Souza, R. Can eosinophilic esophagitis cause achalasia and other esophageal motility disorders? Am. J. Gastroenterol. 113, 1594–1599 (2018).
Jin, H. et al. Activated eosinophils are present in esophageal muscle in patients with achalasia of the esophagus. Med. Sci. Monit. 24, 2377–2383 (2018).
CAS PubMed PubMed Central Google Scholar
Visaggi, P. et al. Systematic review: esophageal motility patterns in patients with eosinophilic esophagitis. Dig. Liver Dis. https://doi.org/10.1016/j.dld.2022.01.003 (2022).
Nelson, M. et al. Lower esophageal sphincter muscle of patients with achalasia exhibits profound mast cell degranulation. Neurogastroenterol. Motil. 33, e14055 (2021).
Zarate, N. et al. Intramuscular interstitial cells of Cajal associated with mast cells survive nitrergic nerves in achalasia. Neurogastroenterol. Motil. 18, 556–568 (2006).
留言 (0)